Centers for Disease Control and Prevention. (2024). Clinical care of strongyloides.
Centers for Disease Control and Prevention. (2024). Clinical treatment of onchocerciasis.
Edenbridge Pharmaceuticals LLC. (2023). Ivermectin tablet [package insert]. DailyMed.
Ikeda T. (2003). [Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy]. Nihon Yakurigaku Zasshi.
Korbmacher, F., et al. (2018). Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo. Parasite Epidemiology and Control.
Martin, D. (2023). Scabies. Centers for Disease Control and Prevention.
Merck Sharp & Dohme LLC. (2023). Stromectol- ivermectin tablet [package insert]. DailyMed.
Olson, B. D., et al. (2006). Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee. The Pediatric Infectious Disease Journal.
Ottesen, E. A. (1987). Description, mechanisms and control of reactions to treatment in the human filariases. Ciba Foundation Symposium.




